Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects
about
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophoreG-protein-coupled receptors signaling pathways in new antiplatelet drug developmentHeme Oxygenase-1 Promotes Delayed Wound Healing in Diabetic RatsCordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue.
P2860
Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@ast
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@en
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@nl
type
label
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@ast
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@en
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@nl
prefLabel
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@ast
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@en
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@nl
P2093
P2860
P1476
Pharmacokinetics and pharmacod ...... inhibitor, in healthy subjects
@en
P2093
Axel Riedel
Brian D Guth
Gerhard Nehmiz
Hans Narjes
Hans-Dieter Schubert
Paul Tanswell
P2860
P356
10.1111/J.1365-2125.2004.02083.X
P407
P577
2004-07-01T00:00:00Z